Post #ISSCR2025 product highlight series – VLP & Nanodisc Displayed Antigens from KACTUS

by | Jul 7, 2025 | Cancer, Drug Discovery, Immunology, Stem Cell, Virology

Post #ISSCR2025 product highlight series by LAB-A-PORTER

KACTUS: VLP & Nanodisc Displayed Antigens for drug discovery

The journey from basic discoveries to clinical applications is often hampered by issues of reproducibility, predictability, and clinical relevance. Building robust in vitro and in vivo studies is essential for validating preclinical findings and ensuring their successful translation.

LAB-A-PORTER is committed to facilitating this by providing researchers globally with suitable reagents and tools. We support researchers on their preclinical research, from discovering drug targets and biomarkers to developing and testing in advanced in vitro and animal models, ultimately helping bridge the gap to clinical success.

In the following weeks, LAB-A-PORTER is going to showcase a series of products that have been highlighted in our booth at ISSCR 2025 Hong Kong, including tools for disease modelling, drug discovery, cell and gene therapy research and tissue engineering research.

This week, we are going to introduce one of our trusted supplier, KACTUS, and their quality VLP & Nanodisc Displayed Antigens used in drug discovery.

KACTUS: VLP & Nanodisc Displayed Antigens for antibody discovery, antibody screening, analytical method development, and immunization.

KACTUS has developed two transmembrane protein display platforms: virus-like particles (VLPs) and nanodiscs. These platforms are designed for functional display of multipass transmembrane proteins in their native conformation.  

Their products are suitable for a range of applications including immunization, ELISA, yeast display, flow cytometry, and SPR. For these applications, choose from unlabeled, biotinylated, or fluorescent proteins. Additionally, their transmembrane proteins undergo bioactivity and purity testing using SPR, ELISA, flow cytometry, and HPLC. This ensures functional performance and batch consistency for reproducible results. Researchers can apply these products to antibody discovery, antibody screening, analytical method development, and immunization.

Explore more on the product catalog of multipass transmembrane proteins displayed on virus-like particles (VLPs) or copolymer nanodiscs by KACTUS.

ABOUT KACTUS

Provides quality recombinant proteins and enzymes that accelerate therapeutic development

Founded in 2018, KACTUS is a leading manufacturer of recombinant proteins and enzymes, providing both off-the-shelf products and custom protein services. Their extensive catalog includes over 3,000 recombinant proteins, featuring antibody drug targets, cytokines, transmembrane proteins, MHC monomers and tetramers, immune checkpoint proteins, biotinylated proteins, and more. They also offer AAV titration ELISA kits, GMP-grade gene editing enzymes, and other GMP enzymes. All their products undergo rigorous testing for purity and bioactivity to ensure quality performance and consistency. KACTUS is ISO 13485:2016 certified and operates state-of-the-art facilities, including a 10,000 sq. meter GMP-grade manufacturing site.

All products listed on this site and sold through LAB-A-PORTER Limited are for research use only (RUO). Not for human use. Not for therapeutic or diagnostic use.

LAB-A-PORTER IS THE OFFICIAL DISTRIBUTOR OF KACTUS IN HONG KONG.

Contact us
Share This